Stock listing
KRX:363250 Genesystem Co., Ltd. (진시스템) 주가
Follow Genesystem Co., Ltd. into a list and get an email when it puts out news.
Share price · KRX:363250
₩3,985.00 KRW -180.00 (-4.3%)
Close on Nov 20, 2026
- Day range
- ₩3,790.00 – ₩4,000.00 KRWNov 20, 2026
- Volume
- 1,722 sharesNov 20, 2026
- Market cap
- ₩33.02B KRWAt the close on Nov 20, 2026 · price × 8.29M shares outstanding
- 52-week range
- ₩2,850.00 – ₩7,260.00 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩30.02M KRWMedian day 5,569 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:363250 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩3,985.00 | -180.00 | -4.3% | ₩3,840.00 | ₩4,000.00 | ₩3,790.00 | 1,722 | |
| ₩4,165.00 | +65.00 | +1.6% | ₩4,105.00 | ₩4,165.00 | ₩3,925.00 | 9,235 | |
| ₩4,100.00 | +175.00 | +4.5% | ₩3,870.00 | ₩4,155.00 | ₩3,860.00 | 15,550 | |
| ₩3,925.00 | -15.00 | -0.4% | ₩3,970.00 | ₩3,970.00 | ₩3,705.00 | 4,054 | |
| ₩3,940.00 | +40.00 | +1.0% | ₩3,895.00 | ₩3,970.00 | ₩3,865.00 | 335 | |
| ₩3,900.00 | 0.00 | 0.0% | ₩3,900.00 | ₩4,000.00 | ₩3,790.00 | 3,323 | |
| ₩3,900.00 | +120.00 | +3.2% | ₩3,820.00 | ₩4,160.00 | ₩3,815.00 | 3,996 | |
| ₩3,780.00 | +5.00 | +0.1% | ₩4,115.00 | ₩4,115.00 | ₩3,780.00 | 1,961 | |
| ₩3,775.00 | -160.00 | -4.1% | ₩3,865.00 | ₩3,865.00 | ₩3,550.00 | 10,367 | |
| ₩3,935.00 | -35.00 | -0.9% | ₩3,620.00 | ₩3,940.00 | ₩3,620.00 | 5,849 | |
| ₩3,970.00 | -130.00 | -3.2% | ₩4,100.00 | ₩4,100.00 | ₩3,865.00 | 9,779 | |
| ₩4,100.00 | +25.00 | +0.6% | ₩4,345.00 | ₩4,345.00 | ₩3,920.00 | 6,365 | |
| ₩4,075.00 | -95.00 | -2.3% | ₩4,160.00 | ₩4,160.00 | ₩3,915.00 | 8,533 | |
| ₩4,170.00 | -170.00 | -3.9% | ₩4,260.00 | ₩4,260.00 | ₩3,955.00 | 11,329 | |
| ₩4,340.00 | +315.00 | +7.8% | ₩3,960.00 | ₩4,420.00 | ₩3,895.00 | 10,040 | |
| ₩4,025.00 | -90.00 | -2.2% | ₩3,995.00 | ₩4,160.00 | ₩3,990.00 | 4,296 | |
| ₩4,115.00 | -5.00 | -0.1% | ₩4,125.00 | ₩4,125.00 | ₩4,100.00 | 412 | |
| ₩4,120.00 | +110.00 | +2.7% | ₩4,050.00 | ₩4,120.00 | ₩3,975.00 | 3,796 | |
| ₩4,010.00 | +25.00 | +0.6% | ₩3,980.00 | ₩4,090.00 | ₩3,870.00 | 5,432 | |
| ₩3,985.00 | -65.00 | -1.6% | ₩4,095.00 | ₩4,095.00 | ₩3,860.00 | 5,463 | |
| ₩4,050.00 | -25.00 | -0.6% | ₩4,000.00 | ₩4,070.00 | ₩3,890.00 | 6,136 | |
| ₩4,075.00 | -25.00 | -0.6% | ₩4,245.00 | ₩4,250.00 | ₩3,950.00 | 5,981 | |
| ₩4,100.00 | -45.00 | -1.1% | ₩4,140.00 | ₩4,140.00 | ₩3,950.00 | 3,533 | |
| ₩4,145.00 | 0.00 | 0.0% | ₩4,075.00 | ₩4,190.00 | ₩4,000.00 | 4,794 | |
| ₩4,145.00 | +245.00 | +6.3% | ₩4,005.00 | ₩4,190.00 | ₩3,870.00 | 4,249 | |
| ₩3,900.00 | -105.00 | -2.6% | ₩3,770.00 | ₩4,055.00 | ₩3,770.00 | 9,477 | |
| ₩4,005.00 | -45.00 | -1.1% | ₩4,030.00 | ₩4,065.00 | ₩3,850.00 | 8,566 | |
| ₩4,050.00 | -50.00 | -1.2% | ₩3,985.00 | ₩4,050.00 | ₩3,985.00 | 12,240 | |
| ₩4,100.00 | +35.00 | +0.9% | ₩4,065.00 | ₩4,185.00 | ₩4,055.00 | 10,435 | |
| ₩4,065.00 | -125.00 | -3.0% | ₩4,110.00 | ₩4,195.00 | ₩4,060.00 | 2,304 | |
| ₩4,190.00 | +40.00 | +1.0% | ₩4,070.00 | ₩4,190.00 | ₩3,950.00 | 3,947 | |
| ₩4,150.00 | -20.00 | -0.5% | ₩4,165.00 | ₩4,170.00 | ₩4,130.00 | 2,530 | |
| ₩4,170.00 | -20.00 | -0.5% | ₩4,165.00 | ₩4,200.00 | ₩4,065.00 | 5,276 | |
| ₩4,190.00 | +10.00 | +0.2% | ₩4,190.00 | ₩4,205.00 | ₩4,155.00 | 10,284 | |
| ₩4,180.00 | +35.00 | +0.8% | ₩4,115.00 | ₩4,335.00 | ₩4,115.00 | 5,544 | |
| ₩4,145.00 | -15.00 | -0.4% | ₩4,345.00 | ₩4,345.00 | ₩4,070.00 | 9,235 | |
| ₩4,160.00 | -40.00 | -1.0% | ₩4,415.00 | ₩4,415.00 | ₩4,150.00 | 5,260 | |
| ₩4,200.00 | +40.00 | +1.0% | ₩4,130.00 | ₩4,490.00 | ₩4,110.00 | 9,691 | |
| ₩4,160.00 | +60.00 | +1.5% | ₩4,490.00 | ₩4,490.00 | ₩4,010.00 | 4,208 | |
| ₩4,100.00 | +70.00 | +1.7% | ₩4,050.00 | ₩4,220.00 | ₩3,965.00 | 16,754 | |
| ₩4,030.00 | -85.00 | -2.1% | ₩4,115.00 | ₩4,120.00 | ₩4,015.00 | 6,029 | |
| ₩4,115.00 | -50.00 | -1.2% | ₩4,140.00 | ₩4,165.00 | ₩4,070.00 | 9,016 | |
| ₩4,165.00 | -15.00 | -0.4% | ₩4,290.00 | ₩4,290.00 | ₩3,900.00 | 19,312 | |
| ₩4,180.00 | -20.00 | -0.5% | ₩4,540.00 | ₩4,540.00 | ₩4,130.00 | 18,069 | |
| ₩4,200.00 | -50.00 | -1.2% | ₩4,220.00 | ₩4,355.00 | ₩4,135.00 | 6,213 | |
| ₩4,250.00 | +190.00 | +4.7% | ₩4,110.00 | ₩4,310.00 | ₩4,015.00 | 21,104 | |
| ₩4,060.00 | +110.00 | +2.8% | ₩3,950.00 | ₩4,225.00 | ₩3,950.00 | 39,917 | |
| ₩3,950.00 | -60.00 | -1.5% | ₩4,050.00 | ₩4,050.00 | ₩3,895.00 | 3,123 | |
| ₩4,010.00 | +15.00 | +0.4% | ₩4,280.00 | ₩4,280.00 | ₩3,975.00 | 6,644 | |
| ₩3,995.00 | -45.00 | -1.1% | ₩4,035.00 | ₩4,035.00 | ₩3,975.00 | 3,422 | |
| ₩4,040.00 | +10.00 | +0.2% | ₩4,200.00 | ₩4,200.00 | ₩3,910.00 | 1,787 | |
| ₩4,030.00 | -10.00 | -0.2% | ₩4,080.00 | ₩4,080.00 | ₩3,975.00 | 3,625 | |
| ₩4,040.00 | 0.00 | 0.0% | ₩4,130.00 | ₩4,130.00 | ₩3,960.00 | 5,065 | |
| ₩4,040.00 | 0.00 | 0.0% | ₩4,040.00 | ₩4,060.00 | ₩3,970.00 | 2,046 | |
| ₩4,040.00 | +5.00 | +0.1% | ₩4,000.00 | ₩4,070.00 | ₩3,900.00 | 5,593 | |
| ₩4,035.00 | +15.00 | +0.4% | ₩4,020.00 | ₩4,085.00 | ₩3,990.00 | 5,209 | |
| ₩4,020.00 | -25.00 | -0.6% | ₩4,175.00 | ₩4,280.00 | ₩3,960.00 | 1,863 | |
| ₩4,045.00 | +45.00 | +1.1% | ₩4,000.00 | ₩4,115.00 | ₩3,960.00 | 4,746 | |
| ₩4,000.00 | -35.00 | -0.9% | ₩3,840.00 | ₩4,045.00 | ₩3,840.00 | 4,479 | |
| ₩4,035.00 | +50.00 | +1.3% | ₩3,830.00 | ₩4,150.00 | ₩3,830.00 | 10,810 | |
| ₩3,985.00 | -65.00 | -1.6% | ₩3,925.00 | ₩4,050.00 | ₩3,910.00 | 5,596 | |
| ₩4,050.00 | +45.00 | +1.1% | ₩3,905.00 | ₩4,090.00 | ₩3,905.00 | 9,580 |
- Ticker
- KRX:363250
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- KRX
- Currency
- KRW
Genesystem Co., Ltd. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
Valuation
EV/sales 29.8× against a median of 0.5×: the highest of 9 Diagnostics & research services companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩30.07B KRW
- P/E
- Loss
- EV/sales
- 29.8×
- EV/EBITDA
- Negative EBITDA
- Price/book
- 2.8×
- Gross margin
- −198.8%
- Operating margin
- −777.3%
- Net margin
- Revenue too small
- Debt to equity
- 0.2×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Genesystem Co., Ltd. · KRX:363250 | US$24.68M | US$22.48M | n/a | 29.8× | n/a | 2.8× | n/a | 0.2× | n/a |
| Bioptic Inc. · TPEX:6850 | US$26.10M | US$22.55M | n/a | n/a | n/a | 2.0× | n/a | 0.2× | n/a |
| genOway SA · EURONEXT:ALGEN | US$25.86M | US$38.95M | 25.4× | 1.7× | 8.7× | 1.1× | 4.4% | 0.7× | n/a |
| Orientbio, Inc. · KRX:002630 | US$25.17M | −US$3.29M | 14.6× | −0.1× | −0.8× | 0.5× | 8.1% | 0.0× | n/a |
| Clever Culture Systems Limited · ASX:CC5 | US$24.56M | US$25.41M | n/a | 8.3× | n/a | 4.9× | −48.4% | 0.4× | n/a |
| CLEO Diagnostics Ltd · ASX:COV | US$24.50M | US$20.38M | n/a | n/a | n/a | 7.4× | n/a | 0.0× | n/a |
| C&R Research Inc. · KRX:359090 | US$24.01M | US$12.51M | 19.3× | 0.3× | 23.4× | 0.7× | 2.6% | 0.0× | n/a |
| HLB Panagene Co. Ltd. · KRX:046210 | US$23.69M | US$6.19M | n/a | 0.6× | n/a | 0.4× | −22.3% | 0.0× | n/a |
| IMBdx, Inc. · KRX:461030 | US$23.63M | US$10.20M | n/a | 2.4× | n/a | 1.4× | −135.5% | 0.0× | n/a |
| QuantaMatrix, Inc. · KRX:317690 | US$23.49M | US$886,824 | n/a | 0.4× | n/a | 1.0× | −567.5% | 0.0× | n/a |
| Genolution Inc. · KRX:225220 | US$23.47M | US$3.42M | n/a | 0.5× | n/a | 0.5× | −46.5% | 0.0× | n/a |
| Median of the others | US$24.26M | US$11.36M | 19.3× | 0.5× | 8.7× | 1.0× | −34.4% | 0.0× |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 381.4M | 1.21B | 897.0M | 3.65B | 13.2B | 13.3B | 1.13B | 498.9M |
| Cost of revenue | 2.85B | 3.03B | 2.48B | 2.49B | 4.57B | 4.27B | 819.3M | 387.7M |
| Gross profit | -2.46B | -1.82B | -1.59B | 1.17B | 8.67B | 8.99B | 315.5M | 111.1M |
| Research and development | 2.69B | 3.34B | 3.43B | 3.35B | 2.84B | 1.63B | ||
| Selling, general and administrative | 1.05B | 3.96B | 4.19B | 4.45B | 3.54B | 3.56B | 1.49B | 1.73B |
| Operating income | -9.69B | -10.1B | -9.48B | -6.60B | 2.27B | 3.33B | -2.49B | -1.62B |
| Depreciation and amortization | 1.02B | 465.8M | 348.9M | 386.3M | 308.1M | 173.9M | 70.6M | |
| EBITDA | -8.67B | -9.65B | -9.14B | -6.22B | 2.57B | 3.50B | -2.42B | |
| Interest expense | 124.6M | 136.2M | 133.6M | 95.5M | 88.9M | 445.6M | 0 | 0 |
| Income before tax | -15.9B | -9.68B | -7.91B | -7.06B | 3.16B | -3.59B | -4.04B | -2.48B |
| Income tax | 1.94B | -386.6M | ||||||
| Net income | -12.0B | -8.92B | -7.92B | -9.00B | 3.55B | -2.22B | -4.04B | -2.48B |
| Earnings per share, basic | -1,752.87 | -1,309.06 | -1,133.23 | -1,298.15 | 516.26 | -326.54 | -593.30 | -363.48 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.11B | 5.62B | 9.09B | 16.8B | 25.6B | 9.06B | 802.1M | 3.21B |
| Short-term investments | 761.3M | 2.00B | 8.31B | 9.65B | 12.0B | 1.82M | ||
| Receivables | 6.55M | 87.9M | 122.2M | 395.5M | 1.87B | 863.2M | 270.6M | 155.5M |
| Inventory | 648.6M | 1.95B | 3.09B | 3.19B | 1.54B | 1.34B | 337.4M | 208.3M |
| Current assets | 2.75B | 9.98B | 21.0B | 30.5B | 41.5B | 11.4B | 1.41B | 3.60B |
| Property, plant and equipment | 8.65B | 6.50B | 6.01B | 6.06B | 5.78B | 265.0M | 191.8M | |
| Goodwill | 0 | 283.1M | 283.1M | |||||
| Total assets | 14.4B | 29.9B | 38.9B | 41.2B | 50.7B | 18.9B | 2.04B | 4.16B |
| Accounts payable | 15.0M | 3.13M | 8.26M | 259.4M | 222.1M | 58.9M | ||
| Current liabilities | 2.54B | 2.54B | 2.43B | 1.97B | 2.64B | 2.67B | 10.9B | 3.97B |
| Long-term debt | 1.94B | 2.26B | 3.04B | 3.00B | 3.00B | 3.00B | 1.91B | 3.08B |
| Total debt | 3.86B | 2.34B | 3.55B | |||||
| Total liabilities | 6.65B | 10.6B | 11.5B | 6.07B | 6.57B | 6.60B | 14.7B | 13.0B |
| Shareholders' equity | 7.85B | 19.3B | 27.5B | 35.1B | 44.1B | 12.3B | -12.7B | -8.85B |
| Shares outstanding | 6.82M | 6.81M | 6.98M | 6.93M | 6.88M | 6.81M | 6.81M | 6.81M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -6.88B | -7.34B | -7.81B | -6.42B | 985.7M | 3.70B | -2.09B | -1.68B |
| Capital spending | -334.3M | -361.1M | -418.8M | -238.4M | -323.9M | -5.78B | -298.1M | -169.1M |
| Free cash flow | -7.22B | -7.70B | -8.23B | -6.74B | 187.5M | -2.09B | -2.39B | -1.85B |
| Cash from investing | 5.57B | -85.4M | -2.56B | -12.9B | -5.76B | -287.9M | -166.6M | |
| Cash from financing | -1.72B | 178.5M | 181.3M | 27.9B | 11.1B | -29.2M | 3.40B | |
| Share buybacks | -1.31B | 242.5M | 224.3M | 29.7B | 7.60B | 3.00B | ||
| Change in cash | -4.51B | -3.47B | -7.75B | -8.79B | 16.6B | 8.26B | -2.41B | 1.56B |
Cap table
Built by 6ix from Genesystem Co., Ltd.’s releases
- Common shares
- 8,286,067
- Fully diluted
- 8,286,067
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 8,286,067 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 8,286,067 |
Log in to ask 6ix AI your own questions about Genesystem Co., Ltd.